Xetal Inc said on Thursday that it has completed all required corporate and regulatory actions in connection with the 1-for-10 reverse split of its common stock approved at a special meeting of the company's shareholders on Aug. 2.
The company said that ratification of the reverse split was a condition for its underwriter to offer and sell to the public about $2.7 million of company common stock and warrants.